NR1H4 and obesity disorder: Molecular modeling subsequently identified glycine-conjugated β-MCA (Gly-β-MCA), a hydrophilic bile acid that is not abundantly synthesized in humans or mice, as an FXR antagonist with anti-obesity and insulin-sensitizing effects in obese mice (17).